Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther Poelman

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Cardiology|July 28, 2018
Cardiac outcome in classic infantile Pompe disease after 13 years of treatment with recombinant human acid alpha-glucosidaseCarine I van Capelle, Esther Poelman, Ingrid M Frohn-Mulder, et al.
The Journal of Pediatrics|February 12, 2018
High Sustained Antibody Titers in Patients with Classic Infantile Pompe Disease Following Immunomodulation at Start of Enzyme Replacement TherapyEsther Poelman, Marianne Hoogeveen-Westerveld, Marian A Kroos-de Haan, et al.
Developmental Medicine and Child Neurology|March 25, 2018
Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brainBerendine J Ebbink, Esther Poelman, Femke K Aarsen, et al.
Journal of Inherited Metabolic Disease|June 8, 2020
Effects of higher and more frequent dosing of alglucosidase alfa and immunomodulation on long-term clinical outcome of classic infantile Pompe patientsEsther Poelman, Jan J A van den Dorpel, Marianne Hoogeveen-Westerveld, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Cardiology|July 28, 2018
Cardiac outcome in classic infantile Pompe disease after 13 years of treatment with recombinant human acid alpha-glucosidaseCarine I van Capelle, Esther Poelman, Ingrid M Frohn-Mulder, et al.
The Journal of Pediatrics|February 12, 2018
High Sustained Antibody Titers in Patients with Classic Infantile Pompe Disease Following Immunomodulation at Start of Enzyme Replacement TherapyEsther Poelman, Marianne Hoogeveen-Westerveld, Marian A Kroos-de Haan, et al.
Developmental Medicine and Child Neurology|March 25, 2018
Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brainBerendine J Ebbink, Esther Poelman, Femke K Aarsen, et al.
Journal of Inherited Metabolic Disease|June 8, 2020
Effects of higher and more frequent dosing of alglucosidase alfa and immunomodulation on long-term clinical outcome of classic infantile Pompe patientsEsther Poelman, Jan J A van den Dorpel, Marianne Hoogeveen-Westerveld, et al.
Pageof 1